Proposed Guidance for Toxicology Testing of Pregnant Patients
This guidance provides recommendations for screening pregnant patients for substance use disorder (SUD) to enhance the well-being of the maternalfetal dyad.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
This guidance provides recommendations for screening pregnant patients for substance use disorder (SUD) to enhance the well-being of the maternalfetal dyad.
This is a best practice guide about using telehealth for the treatment of substance use disorders, including information about screening, brief intervention, and referral to treatment.
A Protocol using empirically-supported behavioral treatments for people with psychoactive stimulant use disorders. There are manuals for healthcare professionals who provide treatment services for individuals with psychoactive substance use disorder (PSUD) and for patients who are entering PSUD treatment.
This revised version of the CRAFFT screening tool incorporates changes that enhance the sensitivity of this well-validated and widely-utilized adolescent substance use screening tool to accurately identify adolescents at risk for a substance use disorder. It also presents new recommended clinician talking points, informed by the latest science and clinician feedback.
This toolkit provides steps and resources such as webinars, worksheets, and workflow examples for implementing screening for substance use disorders into family planning visits.